Earnings
INFI
2.520
-14.00%
-0.410
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
28.59M
5.51M
--
--
--
--
0.00
--
--
--
1.53M
384.00K
36.02M
3.13M
--
--
--
--
--
--
170.00K
3.30M
39.32M
--
2.98M
0.00
--
--
--
--
--
8.06M
--
--
--
--
11.05M
0.00
--
--
--
51.26M
51.26M
62.31M
64.00K
743.27M
-766.32M
--
--
--
-22.99M
-22.99M
39.32M
FY 2019-12-31
22.26M
20.18M
--
--
--
--
0.00
--
--
--
1.68M
457.00K
44.58M
3.90M
--
--
--
--
--
--
530.00K
4.43M
49.01M
--
1.62M
0.00
--
--
--
--
--
8.08M
--
--
--
--
9.70M
0.00
--
--
--
31.59M
31.59M
41.29M
57.00K
733.49M
-725.83M
--
--
--
7.73M
7.73M
49.01M
FY 2018-12-31
48.62M
9.97M
--
--
--
--
0.00
--
--
--
641.00K
586.00K
59.82M
28.00K
--
--
--
--
--
--
369.00K
397.00K
60.22M
--
1.20M
0.00
--
--
--
--
--
6.52M
--
--
--
--
7.72M
0.00
--
--
--
38.00K
38.00K
7.76M
57.00K
731.18M
-678.77M
--
--
--
52.46M
52.46M
60.22M
FY 2017-12-31
34.61M
23.00M
--
--
--
--
0.00
--
--
--
563.00K
214.00K
58.39M
219.00K
--
--
--
--
--
--
748.00K
967.00K
59.35M
--
459.00K
6.00M
--
--
--
--
--
5.14M
--
--
--
--
11.60M
0.00
--
--
--
28.00K
28.00K
11.62M
51.00K
715.21M
-667.52M
--
--
--
47.73M
47.73M
59.35M
FY 2016-12-31
74.06M
18.00M
--
85.00K
--
--
85.00K
--
--
--
3.34M
6.17M
101.66M
23.42M
0.00
--
--
--
--
--
571.00K
24.00M
125.66M
--
2.41M
0.00
--
--
--
--
--
21.01M
--
--
--
0.00
23.86M
19.15M
--
--
--
189.00K
19.34M
43.20M
50.00K
708.10M
-625.69M
--
--
--
82.45M
82.45M
125.66M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out INFI latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Infinity Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.